Fig. 3From: A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malariaKaplan–Meier population at risk of recrudescence by region and age group over time (ITT subset). Note that the y-axis is expanded (survival range 0.5–1.0) to clearly visualise the failure ratesBack to article page